SCHEMBL14904452

SCHEMBL14904452

CC(=O)c1ccc2cc3n(c2c1)CC1(CCNCC1)CNC3=O

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RPS6KA2 Q15349 19/20 0.67
RPS6KA3 P51812 4/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14904446 0.93 RPS6KA2 (0.64) RPS6KA2RPS6KA3
SCHEMBL14904447 0.91 RPS6KA2 (0.66) RPS6KA2RPS6KA3
SCHEMBL12598261 0.89 RPS6KA2 (0.64) RPS6KA2RPS6KA3
SCHEMBL14904449 0.88 RPS6KA2 (0.59) RPS6KA2RPS6KA3
SCHEMBL14904453 0.88 RPS6KA2 (0.58) RPS6KA2RPS6KA3
SCHEMBL1978471 0.86 RPS6KA2 (0.63) RPS6KA2RPS6KA3
SCHEMBL1993378 0.83 RPS6KA2 (0.64) RPS6KA2RPS6KA3
SCHEMBL1985895 0.81 RPS6KA2 (0.65) RPS6KA2RPS6KA3
SCHEMBL12598640 0.81 RPS6KA2 (1.00) RPS6KA2RPS6KA3
SCHEMBL14904455 0.80 RPS6KA2 (0.58) RPS6KA2RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150577-B2 Heterocyclic compounds containing an indole core BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-06 US disclosed
US-20130109679-A1 HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109679-A1 HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE BRSK2, RPS6KA2, RPS6KB2 RPS6KA2 2/4885RPS6KA3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.